Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2019.01770 Immunology Retraction Retraction: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells Frontiers Editorial Office *

Approved by: Catherine Sautes-Fridman, INSERM U1138 Centre de Recherche des Cordeliers, France

 *Correspondence: Frontiers Editorial Office editorial.office@frontiersin.org

This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology

 16 07 2019 2019 10 1770 12 07 2019 12 07 2019 Copyright © 2019 Frontiers Editorial Office. 2019 Frontiers Editorial Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Retraction of the Original Research Article Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells by Zhu, L., Oh, J. M., Gangadaran, P., Kalimuthu, S., Baek, S. H., Jeong, S. Y., et al. (2018). Front. Immunol. 9:824. doi: 10.3389/fimmu.2018.00824

The journal and Chief Editors retract the April 2018 article cited above. Following the publication of the article, concerns regarding the results were addressed to the journal and its Editorial Board. Following clarification with the authors, errors were identified with the data and the article is therefore retracted with the agreement of the authors.